KR102234653B1 - Manufacturing method of bamboo salt water with enhanced anti-fatigue after aerobic exercise - Google Patents
Manufacturing method of bamboo salt water with enhanced anti-fatigue after aerobic exercise Download PDFInfo
- Publication number
- KR102234653B1 KR102234653B1 KR1020200044135A KR20200044135A KR102234653B1 KR 102234653 B1 KR102234653 B1 KR 102234653B1 KR 1020200044135 A KR1020200044135 A KR 1020200044135A KR 20200044135 A KR20200044135 A KR 20200044135A KR 102234653 B1 KR102234653 B1 KR 102234653B1
- Authority
- KR
- South Korea
- Prior art keywords
- bamboo salt
- bamboo
- comparative example
- water
- salt water
- Prior art date
Links
- 235000017166 Bambusa arundinacea Nutrition 0.000 title claims abstract description 91
- 235000017491 Bambusa tulda Nutrition 0.000 title claims abstract description 91
- 241001330002 Bambuseae Species 0.000 title claims abstract description 91
- 235000015334 Phyllostachys viridis Nutrition 0.000 title claims abstract description 91
- 239000011425 bamboo Substances 0.000 title claims abstract description 91
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 title claims abstract description 58
- 150000003839 salts Chemical class 0.000 title claims abstract description 57
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 12
- 230000002929 anti-fatigue Effects 0.000 title description 6
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims abstract description 26
- 230000000694 effects Effects 0.000 claims abstract description 22
- JYGXADMDTFJGBT-VWUMJDOOSA-N hydrocortisone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-VWUMJDOOSA-N 0.000 claims abstract description 20
- 241000332371 Abutilon x hybridum Species 0.000 claims abstract description 15
- 229910052500 inorganic mineral Inorganic materials 0.000 claims abstract description 13
- 235000014655 lactic acid Nutrition 0.000 claims abstract description 13
- 239000004310 lactic acid Substances 0.000 claims abstract description 13
- 239000011707 mineral Substances 0.000 claims abstract description 13
- 241000411851 herbal medicine Species 0.000 claims abstract description 12
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims abstract description 10
- 239000011575 calcium Substances 0.000 claims abstract description 10
- 239000008103 glucose Substances 0.000 claims abstract description 10
- 229960000890 hydrocortisone Drugs 0.000 claims abstract description 10
- 238000000034 method Methods 0.000 claims abstract description 10
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims abstract description 8
- 229910052791 calcium Inorganic materials 0.000 claims abstract description 8
- 230000002708 enhancing effect Effects 0.000 claims abstract description 8
- 230000002401 inhibitory effect Effects 0.000 claims abstract description 4
- 235000002639 sodium chloride Nutrition 0.000 claims description 78
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 45
- 239000011780 sodium chloride Substances 0.000 claims description 25
- 210000004369 blood Anatomy 0.000 claims description 24
- 239000008280 blood Substances 0.000 claims description 24
- 235000010755 mineral Nutrition 0.000 claims description 11
- 230000001954 sterilising effect Effects 0.000 claims description 9
- 238000004659 sterilization and disinfection Methods 0.000 claims description 8
- 238000002386 leaching Methods 0.000 claims description 7
- 241000237502 Ostreidae Species 0.000 claims description 6
- 235000020636 oyster Nutrition 0.000 claims description 6
- 238000009928 pasteurization Methods 0.000 claims description 5
- 238000003756 stirring Methods 0.000 claims description 4
- 239000000126 substance Substances 0.000 claims description 4
- 238000010304 firing Methods 0.000 claims description 3
- 230000028327 secretion Effects 0.000 claims description 3
- 235000012206 bottled water Nutrition 0.000 claims description 2
- 238000002156 mixing Methods 0.000 claims description 2
- 239000000203 mixture Substances 0.000 abstract description 16
- 235000011496 sports drink Nutrition 0.000 abstract description 3
- 108050004114 Monellin Proteins 0.000 abstract description 2
- VRSRXLJTYQVOHC-YEJXKQKISA-N corydaline Chemical compound C=1([C@H]2[C@H]3C)C=C(OC)C(OC)=CC=1CCN2CC1=C3C=CC(OC)=C1OC VRSRXLJTYQVOHC-YEJXKQKISA-N 0.000 abstract 2
- 235000003826 Artemisia Nutrition 0.000 abstract 1
- 235000003261 Artemisia vulgaris Nutrition 0.000 abstract 1
- 240000006891 Artemisia vulgaris Species 0.000 abstract 1
- VRSRXLJTYQVOHC-UHFFFAOYSA-N Corydaline Natural products CC1C2C=3C=C(OC)C(OC)=CC=3CCN2CC2=C1C=CC(OC)=C2OC VRSRXLJTYQVOHC-UHFFFAOYSA-N 0.000 abstract 1
- 241000090365 Filipendula palmata Species 0.000 abstract 1
- 230000009858 acid secretion Effects 0.000 abstract 1
- 235000009052 artemisia Nutrition 0.000 abstract 1
- 235000010436 thaumatin Nutrition 0.000 abstract 1
- 239000000892 thaumatin Substances 0.000 abstract 1
- 230000000052 comparative effect Effects 0.000 description 81
- 206010016256 fatigue Diseases 0.000 description 31
- 230000009182 swimming Effects 0.000 description 12
- 238000010171 animal model Methods 0.000 description 11
- 102000004420 Creatine Kinase Human genes 0.000 description 6
- 108010042126 Creatine kinase Proteins 0.000 description 6
- 241001465754 Metazoa Species 0.000 description 6
- 229940079593 drug Drugs 0.000 description 6
- 239000003814 drug Substances 0.000 description 6
- 238000002474 experimental method Methods 0.000 description 6
- 238000011084 recovery Methods 0.000 description 6
- 239000000284 extract Substances 0.000 description 5
- 230000006698 induction Effects 0.000 description 5
- 239000002994 raw material Substances 0.000 description 5
- 238000012790 confirmation Methods 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 230000003340 mental effect Effects 0.000 description 4
- 206010008874 Chronic Fatigue Syndrome Diseases 0.000 description 3
- 230000002180 anti-stress Effects 0.000 description 3
- 235000013361 beverage Nutrition 0.000 description 3
- 208000035475 disorder Diseases 0.000 description 3
- 230000000517 effect on sleep Effects 0.000 description 3
- 230000003203 everyday effect Effects 0.000 description 3
- 235000003599 food sweetener Nutrition 0.000 description 3
- 230000006872 improvement Effects 0.000 description 3
- 208000029766 myalgic encephalomeyelitis/chronic fatigue syndrome Diseases 0.000 description 3
- 239000003765 sweetening agent Substances 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- 208000019914 Mental Fatigue Diseases 0.000 description 2
- 241000700159 Rattus Species 0.000 description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
- 238000009395 breeding Methods 0.000 description 2
- 230000001488 breeding effect Effects 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 230000037213 diet Effects 0.000 description 2
- 235000013399 edible fruits Nutrition 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 239000004745 nonwoven fabric Substances 0.000 description 2
- 229920001542 oligosaccharide Polymers 0.000 description 2
- 150000002482 oligosaccharides Chemical class 0.000 description 2
- 230000037081 physical activity Effects 0.000 description 2
- 230000001766 physiological effect Effects 0.000 description 2
- 239000011148 porous material Substances 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 230000000452 restraining effect Effects 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- OHVLMTFVQDZYHP-UHFFFAOYSA-N 1-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)-2-[4-[2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidin-5-yl]piperazin-1-yl]ethanone Chemical compound N1N=NC=2CN(CCC=21)C(CN1CCN(CC1)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)=O OHVLMTFVQDZYHP-UHFFFAOYSA-N 0.000 description 1
- HMUNWXXNJPVALC-UHFFFAOYSA-N 1-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]piperazin-1-yl]-2-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethanone Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)N1CCN(CC1)C(CN1CC2=C(CC1)NN=N2)=O HMUNWXXNJPVALC-UHFFFAOYSA-N 0.000 description 1
- VZSRBBMJRBPUNF-UHFFFAOYSA-N 2-(2,3-dihydro-1H-inden-2-ylamino)-N-[3-oxo-3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propyl]pyrimidine-5-carboxamide Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C(=O)NCCC(N1CC2=C(CC1)NN=N2)=O VZSRBBMJRBPUNF-UHFFFAOYSA-N 0.000 description 1
- LDXJRKWFNNFDSA-UHFFFAOYSA-N 2-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)-1-[4-[2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidin-5-yl]piperazin-1-yl]ethanone Chemical compound C1CN(CC2=NNN=C21)CC(=O)N3CCN(CC3)C4=CN=C(N=C4)NCC5=CC(=CC=C5)OC(F)(F)F LDXJRKWFNNFDSA-UHFFFAOYSA-N 0.000 description 1
- WZFUQSJFWNHZHM-UHFFFAOYSA-N 2-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]piperazin-1-yl]-1-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethanone Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)N1CCN(CC1)CC(=O)N1CC2=C(CC1)NN=N2 WZFUQSJFWNHZHM-UHFFFAOYSA-N 0.000 description 1
- IHCCLXNEEPMSIO-UHFFFAOYSA-N 2-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]piperidin-1-yl]-1-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethanone Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C1CCN(CC1)CC(=O)N1CC2=C(CC1)NN=N2 IHCCLXNEEPMSIO-UHFFFAOYSA-N 0.000 description 1
- YLZOPXRUQYQQID-UHFFFAOYSA-N 3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)-1-[4-[2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidin-5-yl]piperazin-1-yl]propan-1-one Chemical compound N1N=NC=2CN(CCC=21)CCC(=O)N1CCN(CC1)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F YLZOPXRUQYQQID-UHFFFAOYSA-N 0.000 description 1
- 208000007848 Alcoholism Diseases 0.000 description 1
- 208000000044 Amnesia Diseases 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 241001573881 Corolla Species 0.000 description 1
- 241000218165 Dioscoreophyllum Species 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108010021582 Glucokinase Proteins 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 1
- 208000026139 Memory disease Diseases 0.000 description 1
- 206010068319 Oropharyngeal pain Diseases 0.000 description 1
- CBENFWSGALASAD-UHFFFAOYSA-N Ozone Chemical compound [O-][O+]=O CBENFWSGALASAD-UHFFFAOYSA-N 0.000 description 1
- 235000002789 Panax ginseng Nutrition 0.000 description 1
- 241000282376 Panthera tigris Species 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- 244000228451 Stevia rebaudiana Species 0.000 description 1
- 239000004383 Steviol glycoside Substances 0.000 description 1
- 241000234568 Thaumatococcus Species 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 201000007930 alcohol dependence Diseases 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 230000037007 arousal Effects 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000006399 behavior Effects 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- -1 calcium Chemical compound 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 210000004720 cerebrum Anatomy 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 210000000750 endocrine system Anatomy 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 235000013376 functional food Nutrition 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 235000003642 hunger Nutrition 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000005923 long-lasting effect Effects 0.000 description 1
- 239000008176 lyophilized powder Substances 0.000 description 1
- 238000000691 measurement method Methods 0.000 description 1
- 230000006984 memory degeneration Effects 0.000 description 1
- 208000023060 memory loss Diseases 0.000 description 1
- 230000037323 metabolic rate Effects 0.000 description 1
- 208000030247 mild fever Diseases 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 230000008447 perception Effects 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- HELXLJCILKEWJH-NCGAPWICSA-N rebaudioside A Chemical compound O([C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HELXLJCILKEWJH-NCGAPWICSA-N 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 208000019116 sleep disease Diseases 0.000 description 1
- 208000022925 sleep disturbance Diseases 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000012453 sprague-dawley rat model Methods 0.000 description 1
- 239000008223 sterile water Substances 0.000 description 1
- 235000019411 steviol glycoside Nutrition 0.000 description 1
- 229930182488 steviol glycoside Natural products 0.000 description 1
- 150000008144 steviol glycosides Chemical class 0.000 description 1
- 235000019202 steviosides Nutrition 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 230000001960 triggered effect Effects 0.000 description 1
- 239000008513 turmeric extract Substances 0.000 description 1
- 229940052016 turmeric extract Drugs 0.000 description 1
- 235000020240 turmeric extract Nutrition 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
- A23L2/38—Other non-alcoholic beverages
-
- A23L2/46—
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
- A23L2/52—Adding ingredients
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
- A23L2/70—Clarifying or fining of non-alcoholic beverages; Removing unwanted matter
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
Landscapes
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Description
본 발명은 애엽, 현호색, 도라지잎, 제주조릿대 등의 생약을 칼슘이 강화된 죽염 생수에 저온침지하고 모넬린 및 타우마틴을 첨가함으로써 유산소 운동 후의 피로 완화 효능이 증강되고 청량감이 개선된 죽염수를 제조하는 방법에 관한 것이다. The present invention prepares bamboo salt water with improved refreshing feeling and enhanced fatigue relief effect after aerobic exercise by immersing herbal medicines such as aeropsis, hyeonhosaek, bellflower leaves, and Jeju joritdae in calcium-enriched bamboo salt mineral water and adding monelin and taumartin to relieve fatigue after aerobic exercise. It's about how to do it.
피로(fatigue)는 때때로 '활동을 수행하기 위해 필요한 자원들의 가용, 활용 및 회복에서의 불균형으로 인한 신체적 및 정신적 활성에 대한 감소된 능력의 지각'으로 정의 될 수 있으며, 구체적으로는 피로는 주로 육체적 피로로 작업능력이 저하되는 상태, 그리고 스트레스는 정신적 피로로 항산성의 혼란이 일어나는 상태를 말한다(식약청 건강기능식품의 피로회복 관련 기능성 평가체계 구축, 연구보고서). 피로는 중추신경계 피로, 신경-근육의 접합부의 피로와 지체의 말초 피로로 분류된다. 피로는 다양한 생리학적 및 생화학적 인자를 비롯한 포괄적인 생리학인 과정이며, 신체의 정신 활동이나 신체활동이 일정한 단계에 도달할 때 필연적으로 나타나는 정신적인 생리현상이다. 이는 인체 본래의 작업 능력이 일시적으로 저하되는 것을 의미하고, 신체가 손상 상태로 발전하는 것을 나타내는 증상일 수 있다. Fatigue can sometimes be defined as'the perception of a reduced capacity for physical and mental activity due to an imbalance in the availability, utilization and recovery of resources needed to carry out an activity', specifically, fatigue is primarily physical. Workability is reduced due to fatigue, and stress refers to a state in which acidic confusion occurs due to mental fatigue (establishment of a functional evaluation system related to fatigue recovery of health functional foods from the KFDA, research report). Fatigue is classified into central nervous system fatigue, nerve-muscle junction fatigue, and peripheral fatigue of the body. Fatigue is a comprehensive physiological process including various physiological and biochemical factors, and is a mental physiological phenomenon that inevitably appears when the body's mental or physical activity reaches a certain stage. This means that the human body's original work ability is temporarily deteriorated, and may be a symptom indicating that the body develops into a damaged state.
피로가 지속적으로 발생하면 만성적인 상태가 되면 만성피로 증후군이라는 질병으로 발전되기도 한다. 현재 만성 피로 증후군(Chronic Fatigue Syndrome, CFS)의 주요 증상으로 장기간 지속되는 피로감은 미열, 두통, 인후통, 근육 관절통, 주의력 집중 장애, 기억력 저하, 수면 장애 및 우울증 등의 비특이적인 증상과 함께 갖는 일군의 증후군이고, 신체검사와 상규검사의 경우 일반적으로 뚜렷한 이상이 없다(Holmes GO, er al, Amm. Intern Med, 1988, 108 (3)). 피로를 일으키는 원인으로는 수면부족, 운동부족, 불균형 식이, 알코올 중독과 같은 나쁜 습관, 정신적 압박, 나쁜 작업 환경, 직장 환경 등 다양하다.If fatigue continues to occur, a chronic condition may develop into a disease called chronic fatigue syndrome. Currently, the main symptom of Chronic Fatigue Syndrome (CFS), long-lasting fatigue is a group of non-specific symptoms such as mild fever, headache, sore throat, muscle joint pain, attention-focusing disorder, memory loss, sleep disturbance and depression. It is a syndrome, and there is generally no obvious abnormality in the case of physical examination and regular examination (Holmes GO, er al, Amm. Intern Med, 1988, 108 (3)). There are various causes of fatigue such as lack of sleep, lack of exercise, unbalanced diet, bad habits such as alcoholism, mental pressure, bad work environment, and work environment.
피로 완화방법으로는 휴식을 취하는 방법, 만족스러운 일을 찾는 것, 규칙적인 운동, 더 나은 식이로의 변화 및 충분한 잠을 포함하는 여러 가지 접근 방법들이 존재한다. 하지만, 특정한 피로 해소 방법 수행으로 육체적 및 생리적인 피로감을 단기에 해소하기는 어려움이 있다. 따라서 육체적 및 정신적인 피로감 해소, 특히 면역력 저하, 신경계 및 내분비계의 장애, 비정상적인 혈관계 및 소화 장애 등의 극복에 도움을 주는 제품개발이 요구되나 이에 관련된 효과를 갖는 제품 개발은 아직 없는 상황이며, 카페인 같은 각성효과를 가지는 약물이 피로개선을 위한 약물로 사용되고 있으나 실제 혈중 피로물질을 감소시키는 효과는 없다.There are several approaches to relieving fatigue, including rest, finding a satisfying job, regular exercise, changing to a better diet, and getting enough sleep. However, it is difficult to relieve physical and physiological fatigue in a short time by performing a specific method of relieving fatigue. Therefore, there is a need to develop a product that helps relieve physical and mental fatigue, especially to overcome immunity decline, disorders of the nervous and endocrine systems, abnormal vascular and digestive disorders, but there is no development of a product with related effects. Drugs with the same arousal effect are used as drugs to improve fatigue, but they do not actually reduce blood fatigue substances.
본 발명자들은 각종 생리활성을 증진시킬 수 있는 조성물을 연구하던 중, 죽염을 이용한 스포츠음료 조성물이 스트레스 완화 또는 항피로 효능이 뛰어남을 확인하여 본 발명을 완성하게 되었다. The present inventors have completed the present invention by confirming that a sports drink composition using bamboo salt has excellent stress relief or anti-fatigue efficacy while researching a composition capable of enhancing various physiological activities.
본 발명의 목적은 애엽, 현호색, 도라지잎, 제주조릿대 등의 생약을 칼슘이 강화된 죽염 생수에 저온침지하고 모넬린 및 타우마틴을 첨가함으로써 유산소 운동 후의 피로 완화 효능이 증강되고 청량감이 개선된 죽염수를 제조하는 방법을 제공하는 데에 있다. The object of the present invention is to immerse herbal medicines such as aeropsis, hyeonhosaek, bellflower leaves, and Jeju joritdae in calcium-enriched bamboo salt mineral water, and add monelin and taumatin, thereby enhancing the effect of relieving fatigue after aerobic exercise and improving the refreshing feeling. It is to provide a method of manufacturing.
본 발명은 유산소 운동 후의 피로 완화용 죽염수의 제조방법에 관한 것으로서, 상기 죽염수는 하기 단계를 포함하여 제조될 수 있다. The present invention relates to a method of manufacturing bamboo salt water for relieving fatigue after aerobic exercise, wherein the bamboo salt water may be prepared including the following steps.
바람직하게는, (제1단계) 천일염과 대나무 및 굴껍질을 혼합하여 900~1200℃에서 6~24시간 소성하여 CaO를 함유하는 죽염을 제조하는 단계;Preferably, (1st step) preparing bamboo salt containing CaO by mixing the sea salt with bamboo and oyster shells and firing at 900 to 1200° C. for 6 to 24 hours;
(제2단계) 상기 죽염을 염도 0.8~1.0 %(w/v)가 되도록 생수에 현탁하여 1~4시간 동안 4~10℃에서 10~30rpm으로 교반한 후 불용성 물질을 제거하여 칼슘(Ca2+) 함량이 증강된 죽염생수를 제조하는 단계;(Second step) The bamboo salt is suspended in mineral water so that its salinity is 0.8 to 1.0% (w/v), stirred at 4 to 10°C for 1 to 4 hours at 10 to 30 rpm, and then insoluble substances are removed to remove calcium (Ca 2 + ) Preparing bamboo salt mineral water with enhanced content;
(제3단계) 상기 제2단계에서 얻은 죽염생수에 애엽, 현호색, 도라지잎, 제주조릿대를 넣고 18~24시간 동안 4~10℃에서 10~30rpm으로 교반한 후 여과하여 생약침출 죽염생수를 제조하는 단계;(3rd step) Into the bamboo salted water obtained in the second step, add aeop, hyeonho color, bellflower leaves, and jeju joritdae, stir at 4 to 10°C for 18 to 24 hours at 10 to 30 rpm, and then filter to prepare a herbal medicine leaching bamboo salt water. The step of doing;
(제4단계) 상기 제3단계에서 얻은 생약침출 죽염생수를 62~65℃에서 30~40분간 유지하여 저온살균하는 단계; 및, (Step 4) Pasteurizing by maintaining the herbal medicine leaching bamboo salt water obtained in the third step at 62 to 65°C for 30 to 40 minutes; And,
(제5단계) 저온살균 후 생약침출 죽염생수에 모넬린 및 타우마틴을 첨가하고 자외선 살균하여 멸균팩에 봉입하는 단계; (Step 5) adding monelin and taumatin to the herbal medicine leaching bamboo salt water after pasteurization, sterilizing with ultraviolet rays, and encapsulating in a sterilization pack;
를 함유할 수 있다. It may contain.
상기 제1단계의 천일염, 대나무 및 굴껍질은 1:0.5:0.5 내지 1:2:2의 중량비로 혼합하는 것이 바람직하다. It is preferable to mix the sea salt, bamboo and oyster shells of the first step in a weight ratio of 1:0.5:0.5 to 1:2:2.
상기 제3단계에서 죽염생수 100 중량부 기준으로 애엽 3~5 중량부, 현호색 3~5 중량부, 도라지잎 5~7 중량부, 제주조릿대 2~4 중량부를 첨가할 수 있다. In the third step, based on 100 parts by weight of bamboo salt mineral water, 3 to 5 parts by weight of aeyeop, 3 to 5 parts by weight of hyeonho color, 5 to 7 parts by weight of bellflower leaves, and 2 to 4 parts by weight of Jeju joritdae may be added.
상기 제5단계에서 생약침출 죽염생수 100 중량부 기준으로 모넬린 0.5~1 중량부 및 타우마틴 0.5~1 중량부를 첨가하는 것이 바람직하다. In the fifth step, it is preferable to add 0.5 to 1 parts by weight of monelin and 0.5 to 1 parts by weight of taumatin based on 100 parts by weight of herbal leaching bamboo salt water.
본 발명은 상기 방법으로 제조한 유산소 운동 후의 피로 완화용 죽염수를 제공한다. The present invention provides bamboo salt water for relieving fatigue after aerobic exercise prepared by the above method.
상기 죽염수는 코티졸, 포스포키나아제 또는 젖산 분비를 억제하는 효능이 있는 것을 특징으로 한다. The bamboo saline solution is characterized in that it has the effect of inhibiting the secretion of cortisol, phosphokinase or lactic acid.
상기 죽염수는 혈액 내 글루코오스 소모량을 증강시키는 효능이 있다. The bamboo saline solution has the effect of enhancing the amount of glucose consumed in the blood.
본 발명에서 사용하는 모넬린(monellin)과 타우마틴(thaumatin)은 추출대상 식물의 열수 추출물로부터 정제하고, 건조 전 최종 수용액 상태에서 UV 조사 및 오존 살균된 것을 사용할 수 있다. 또한 동결건조된 분말을 사용하는 것이 더 좋다. Monellin and taumatin used in the present invention may be purified from hot water extracts of plants to be extracted, and UV irradiated and ozone sterilized in a final aqueous solution before drying. It is also better to use lyophilized powder.
상기 모넬린은 Dioscoreophyllum cummisii 열매에 포함되고 있는 감미료이며, 상기 타우마틴은 Thaumatococcus danielli의 과실에 포함하고 있는 감미성분이다. The monelin is a sweetener contained in the fruit of Dioscoreophyllum cummisii , and the taumartin is a sweetening component contained in the fruit of Thaumatococcus danielli.
본 발명은 애엽, 현호색, 도라지잎, 제주조릿대 등의 생약을 칼슘이 강화된 죽염 생수에 저온침지하고 모넬린 및 타우마틴을 첨가하여 죽염수를 제조하는 방법에 관한 기술로서, 상기 죽염수는 코티졸, 포스포키나아제 또는 젖산 분비를 억제하는 효능이 있으면서 글루코오스 소모량을 증강시켜 유산소 운동 후의 피로 완화용 스포츠 음료 조성물이나 이온음료 조성물, 재활 환자의 활력 증강용 음료 조성물 등으로 용이하게 이용가능하다. The present invention relates to a method for preparing bamboo salt water by immersing herbal medicines such as aerobium, hyeonhosaek, bellflower leaf, and Jeju joritdae in calcium-enriched bamboo salt mineral water, and adding monelin and taumatin to prepare bamboo salt water, wherein the bamboo salt water is cortisol, pos While having the effect of inhibiting the secretion of pokinase or lactic acid, it can be easily used as a sports drink composition or ionic drink composition for relieving fatigue after aerobic exercise by enhancing the amount of glucose consumption, and a beverage composition for enhancing vitality of rehabilitation patients.
이하 본 발명의 바람직한 실시예를 상세히 설명하기로 한다. 그러나, 본 발명은 여기서 설명되는 실시예에 한정되지 않고 다른 형태로 구체화될 수도 있다. 오히려, 여기서 소개되는 내용이 철저하고 완전해지도록, 당업자에게 본 발명의 사상을 충분히 전달하기 위해 제공하는 것이다. Hereinafter, a preferred embodiment of the present invention will be described in detail. However, the present invention is not limited to the embodiments described herein and may be embodied in other forms. Rather, it is provided to sufficiently convey the spirit of the present invention to those skilled in the art so that the contents introduced herein are thorough and complete.
<실시예 1 내지 5. 죽염수의 제조><Examples 1 to 5. Preparation of bamboo salt water>
실시예 1Example 1
천일염, 대나무(2~5cm 내외로 세절한 대나무 조각) 및 굴껍질을 동일 중량으로 혼합하여 100℃에서 12시간 소성하여 CaO를 함유하는 죽염을 제조하였다(기존에는 대나무 통 안에 천일염만을 넣어 이를 여러번 소성하여 죽염을 제조함). Natural sea salt, bamboo (bamboo pieces cut into 2~5cm) and oyster shells were mixed at the same weight and fired at 100℃ for 12 hours to produce bamboo salt containing CaO (previously, only sea salt was put in a bamboo barrel and fired several times. To manufacture bamboo salt).
상기 죽염을 생수에 녹여 염도(NaCl 농도)가 0.9%(w/v)가 되도록 조절하였다. 이 후 1시간 동안 4℃에서 20rpm으로 교반하여 칼슘을 비롯한 굴껍질에서 소성되어 나온 수용성 성분들이 충분히 생수에 용해되게 하였다. 다음으로는 10000rpm에서 30분간 원심분리하여 얻은 상층액을 부직포 필터, 거름종이 필터 및 0.2μm 기공을 갖는 필터를 순차적으로 적용하여 여과하였다. The bamboo salt was dissolved in mineral water and the salinity (NaCl concentration) was adjusted to 0.9% (w/v). After that, the mixture was stirred at 4° C. for 1 hour at 20 rpm to ensure that the water-soluble components calcined from the oyster shell, including calcium, were sufficiently dissolved in bottled water. Next, the supernatant obtained by centrifugation at 10000 rpm for 30 minutes was filtered by sequentially applying a nonwoven fabric filter, a filter paper filter, and a filter having 0.2 μm pores.
여과하여 얻은 죽염생수 100g 기준 애엽 4g, 현호색 4g, 도라지잎 6g, 제주조릿대 3g을 넣고 24시간 동안 4℃에서 20rpm으로 교반한 후 건더기를 제거하여 생약침출 죽염생수를 제조하였다. 이 후 상기 생약침출 죽염생수를 65℃에서 30분간 유지하여 저온살균하고, 저온살균 후 생약침출 죽염생수 100g 기준으로 모넬린 1g 및 타우마틴 0.5g을 첨가하고 자외선 살균하여 멸균팩에 봉입하였다. Based on 100 g of the bamboo salt water obtained by filtration, 4 g of aeyeop, 4 g of Hyeonho color, 6 g of bellflower leaves, and 3 g of Jeju joritdae were added, and the mixture was stirred at 4°C for 24 hours at 20 rpm, and then the ingredients were removed to prepare a herbal medicine leached bamboo salt water. Thereafter, the crude drug leached bamboo salt water was kept at 65° C. for 30 minutes to pasteurize, and after pasteurization, monelin 1 g and taumatin 0.5 g were added based on 100 g of the crude drug leached bamboo salt water, and ultraviolet sterilization was enclosed in a sterilization pack.
실시예 2Example 2
실시예 1과 동일하게 죽염수를 제조하되, 제조과정 중의 원료 중량을, 애엽 3g, 현호색 5g, 도라지잎 5g, 제주조릿대 4g을 넣었다. Bamboo salt water was prepared in the same manner as in Example 1, but the weight of the raw material during the manufacturing process was 3g of aeyeop, 5g of Hyeonho color, 5g of bellflower leaves, and 4g of Jeju joritdae.
실시예 3Example 3
실시예 1과 동일하게 죽염수를 제조하되, 제조과정 중의 원료 중량을, 애엽 5g, 현호색 3g, 도라지잎 7g, 제주조릿대 2g을 넣었다. Bamboo salt water was prepared in the same manner as in Example 1, but the weight of raw materials during the manufacturing process was put in 5 g of aeyeop, 3 g of hyeonho color, 7 g of bellflower leaves, and 2 g of Jeju joritdae.
실시예 4Example 4
실시예 1과 동일하게 죽염수를 제조하되, 제조과정 중의 원료 중량을, 모넬린 0.5g, 타우마틴 1g을 넣었다. Bamboo salt water was prepared in the same manner as in Example 1, but the weight of the raw material during the manufacturing process was 0.5 g of monelin and 1 g of taumatin were added.
비교예 1Comparative Example 1
실시예 1과 동일하게 죽염수를 제조하되, 제조과정 중의 원료 중량을, 애엽 1g, 현호색 7g, 도라지잎 1g, 제주조릿대 8g, 모넬린 1g 및 타우마틴 0.5g로 조절하였다. Bamboo salt water was prepared in the same manner as in Example 1, but the weight of the raw materials during the manufacturing process was adjusted to 1 g of aeropsis, 7 g of hyeonho saek, 1 g of bellflower leaves, 8 g of Jeju joritdae, 1 g of monelin, and 0.5 g of taumatin.
비교예 2Comparative Example 2
실시예 1과 동일하게 죽염수를 제조하되, 제조과정 중의 원료 중량을, 애엽 10g, 현호색 13g을 넣고 도라지잎과 제주조릿대는 넣지 않았으며, 모넬린 1.5g을 넣고 타우마틴은 넣지 않았다. Bamboo salt water was prepared in the same manner as in Example 1, but the weight of the raw material during the manufacturing process was 10 g of aerobium, 13 g of hyeonho color, and no bellflower leaves and jeju joritdae were added, and 1.5 g of monelin was added and no taumatin was added.
비교예 3Comparative Example 3
실시예 1과 동일하게 죽염수를 제조하되, 모넬린과 타우마틴 대신 효소처리 스테비아 추출물(스테비올 배당체 95%이상)을 1.5g 넣었다. Bamboo saline was prepared in the same manner as in Example 1, but 1.5g of enzyme-treated stevia extract (steviol glycoside 95% or more) was added instead of monelin and taumartin.
비교예 4Comparative Example 4
실시예 1과 동일하게 죽염수를 제조하되, 모넬린 0.2g, 타우마틴 2g을 넣었다. Bamboo saline was prepared in the same manner as in Example 1, but 0.2 g of monelin and 2 g of taumatin were added.
비교예 5Comparative Example 5
실시예 1과 동일하게 죽염수를 제조하되, 모넬린과 타우마틴 대신 올리고당을 1.5g 넣었다. Bamboo saline was prepared in the same manner as in Example 1, but 1.5 g of oligosaccharide was added instead of monelin and taumartin.
비교예 6Comparative Example 6
실시예 1과 동일하게 죽염수를 제조하되, 저온살균 대신 121℃, 1.5기압에서 15분 조건으로 고온고압 멸균을 하였다. Bamboo salt water was prepared in the same manner as in Example 1, but high-temperature and high-pressure sterilization was performed at 121° C. and 1.5 atmospheres for 15 minutes instead of pasteurization.
비교예 7Comparative Example 7
실시예 1과 동일하게 죽염수를 제조하되, 천일염과 대나무 및 굴껍질을 이용하여 제조한 죽염 대신 시판용 죽염(대나무 통 속에 천일염을 넣어 제조한 것)을 이용하여 죽염수를 이용하였다. Bamboo salt water was prepared in the same manner as in Example 1, but bamboo salt water was used using commercially available bamboo salt (made by putting the sea salt in a bamboo barrel) instead of bamboo salt prepared using natural sea salt and bamboo and oyster bark.
비교예 8Comparative Example 8
천일염으로 제조한 0.9%(w/v) 소금물에 애엽, 현호색, 도라지잎, 제주조릿대를 실시예 1과 동량으로 넣고 이후의 과정은 실시예 1 방법대로 음료 조성물을 제조하였다. In 0.9% (w/v) salt water prepared with sea salt, aeop, hyeonho saek, bellflower leaves, and jeju joritdae were added in the same amount as in Example 1, and a beverage composition was prepared according to the method of Example 1.
비교예 9Comparative Example 9
시판되는 염도 0.9%(w/v)의 일반 생리 식염수에 애엽, 현호색, 도라지잎, 제주조릿대를 실시예 1과 동량으로 넣고 이후의 과정은 실시예 1 방법대로 음료 조성물을 제조하였다. In a commercially available general physiological saline solution having a salinity of 0.9% (w/v), aeyeop, corolla, bellflower leaves, and Jeju joritdae were added in the same amount as in Example 1, and a beverage composition was prepared according to the method of Example 1.
비교예 10Comparative Example 10
일반 생수 100g 기준 애엽 4g, 현호색 4g, 도라지잎 6g, 제주조릿대 3g을 넣고 24시간 동안 4℃에서 20rpm으로 교반하여 생약침출수를 제조하고, 이 때 천일염/대나무/굴껍질을 소성하여 제조한 죽염을 넣어 염도를 0.9%(w/v)으로 조절하였으며, 1시간 동안 4℃에서 20rpm으로 교반하여 칼슘을 비롯한 굴껍질에서 소성되어 나온 수용성 성분들이 충분히 생수에 용해되게 하였다. 다음으로는 10000rpm에서 30분간 원심분리하여 얻은 상층액을 부직포 필터, 거름종이 필터 및 0.2μm 기공을 갖는 필터를 순차적으로 적용하여 여과하였다. 이 후 상기 생약침출수를 65℃에서 30분간 유지하여 저온살균하고, 저온살균 후 생약침출수 100g 기준으로 모넬린 1g 및 타우마틴 0.5g을 첨가하고 자외선 살균하여 멸균팩에 봉입하였다. Herbal medicine leachate was prepared by adding 4g of aerobatic leaves, 4g of brown tiger color, 6g of bellflower leaves, and 3g of Jeju joritdae based on 100g of normal mineral water, and stirring at 4℃ at 20rpm for 24 hours.At this time, bamboo salt prepared by firing sea salt/bamboo/oyster bark was used. The salinity was adjusted to 0.9% (w/v), and the water-soluble components calcined from the oyster shell including calcium were sufficiently dissolved in mineral water by stirring at 20 rpm at 4° C. for 1 hour. Next, the supernatant obtained by centrifugation at 10000 rpm for 30 minutes was filtered by sequentially applying a nonwoven fabric filter, a filter paper filter, and a filter having 0.2 μm pores. Thereafter, the crude drug leachate was kept at 65° C. for 30 minutes to pasteurize, and after pasteurization, 1 g of monelin and 0.5 g of taumatin were added based on 100 g of the crude drug leachate, followed by ultraviolet sterilization and enclosed in a sterilization pack.
<실험예 1. 실험동물의 준비 및 시료 투여><Experimental Example 1. Preparation of experimental animals and administration of samples>
실험예 1-1. 실험동물의 사육 및 죽염수 투여Experimental Example 1-1. Breeding of experimental animals and administration of bamboo saline
실험동물로 체중 170~180 g 범위의 Sprague-Dawley의 수컷 흰쥐를 (주)대한바이오링크(음성, 한국)에서 구입하였다. 사육환경은 온도 20±2℃, 습도 55±1%(RH), 명암주기 12시간 간격으로 유지하여 1주일간 순환시켰다. 사료는 실험동물용 고형사료 (PMI Nutrition International)를 매일 일정한 시간에 일정량을 주었고, 물은 멸균수를 물병을 이용하여 자유롭게 섭취하도록 하였다. As experimental animals, male rats of Sprague-Dawley, weighing 170-180 g, were purchased from Daehan Biolink Co., Ltd. (Eumseong, Korea). The breeding environment was maintained at 20±2℃ temperature, 55±1% (RH) humidity, and 12 hour intervals of light and dark cycles, and circulated for 1 week. The feed was given a certain amount of solid feed for experimental animals (PMI Nutrition International) at a certain time every day, and the water was freely ingested using sterile water using a water bottle.
또한 실험 전 실시예 1 내지 4, 비교예 1 내지 10의 죽염수 또는 식염수를 각 실험동물 개체군(군당 8마리)에 매일 1㎖씩 2주간 경구투여하여 진행하였다. In addition, before the experiment, the bamboo saline or saline solution of Examples 1 to 4 and Comparative Examples 1 to 10 was orally administered 1 ml each day to each experimental animal population (8 animals per group) for 2 weeks.
<실험예 2. 항 스트레스 효과 확인><Experimental Example 2. Anti-stress effect confirmation>
실험예 2-1. 구속 스트레스 유도 및 혈액채취Experimental Example 2-1. Induction of restraint stress and blood collection
각각의 죽염수 또는 식염수(실시예 1 내지 4, 비교예 1 내지 10)를 2주간 투여한 동물 그룹에 구속 스트레스를 가했다. Restraint stress was applied to a group of animals to which each bamboo saline solution or saline solution (Examples 1 to 4 and Comparative Examples 1 to 10) was administered for 2 weeks.
구속 스트레스를 가하는 방법은 항스트레스 조성물로서 각각의 죽염수 또는 식염수를 2주간 섭취시킨 실험동물을 투명 case(40cm×30cm×30cm)안에 넣어 매일 17:00∼18:00에 1시간씩 case를 진동기에 올려놓은 다음 진동(2km/hr)시키는 방법으로 7일간 실시하였다. 이 때 구속 스트레스를 가하는 기간에도 각 죽염수 또는 식염수를 투여하였다.The method of applying restraint stress is an anti-stress composition. Each experimental animal ingested with bamboo saline or saline solution for 2 weeks is placed in a transparent case (40cm×30cm×30cm), and the case is placed in a vibrator for 1 hour every day from 17:00 to 18:00. After placing, it was carried out for 7 days by vibrating (2km/hr). At this time, each bamboo saline solution or saline solution was administered even during the period of applying restraint stress.
7일간의 구속 스트레스 완료 10분 후에 각 실험동물을 마취한 다음 희생하여 분석시료(혈청 혹은 혈장 등)를 채취하여, 다음의 실험에서 항 스트레스 효과를 평가하기 위한 바이오메커로서 혈액에서의 코티솔(cortisol), 젖산(lactic acid), 글루코오스(glucose), 크레아틴 포스포키나아제(creatine phosphokinase)의 양을 측정하였다. 10 minutes after completion of the 7-day restraint stress, each experimental animal is anesthetized and sacrificed, and an analysis sample (serum or plasma, etc.) is collected, and cortisol in blood is used as a biomechanical to evaluate the anti-stress effect in the next experiment. ), lactic acid, glucose, and creatine phosphokinase were measured.
실험예 2-2. 혈액 내 코티솔(Cortisol)의 양 비교 Experimental Example 2-2. Comparison of the amount of cortisol in the blood
스트레스가 유발될 때, 인체에서는 코티솔을 분비하여 대사율을 떨어트리고, 대뇌의 식욕중추를 자극하여 허기가 지지 않아도 음식물 섭취를 하도록 작용한다(Adam TC, Epel ES. Stress, eating and the reward system. Physiology and Behavior. 2007. 91(4):449-458).When stress is triggered, the human body secretes cortisol to lower the metabolic rate, stimulates the appetite center of the cerebrum, and acts to consume food without hunger (Adam TC, Epel ES. Stress, eating and the reward system. Physiology and Behavior. 2007. 91(4):449-458).
이에 구속 스트레스 유도 후 각 죽염수 또는 식염수가 투여된 동물의 혈액 내 코티솔(Cortisol)의 양을 표 1에 나타내었다. Accordingly, Table 1 shows the amount of cortisol in the blood of animals administered with bamboo saline or saline solution after induction of restraint stress.
혈중 코티솔 함량 (㎍/㎗)Post restraint stress
Blood cortisol content (㎍/㎗)
표 1에서 보듯이, 혈중 코티솔이 실시예 1 내지 5의 죽염수를 투여한 군에서 가장 낮게 나오는 것을 확인할 수 있다.As shown in Table 1, it can be seen that the blood cortisol is the lowest in the group to which the bamboo saline solution of Examples 1 to 5 was administered.
실험예 2-3 크레아틴 포스포키나아제의 양 비교Experimental Example 2-3 Comparison of the amount of creatine phosphokinase
혈액 내 크레아틴 포스포키나아제의 농도가 구속 스트레스를 받은 실험동물에서 증가되었다는 보고가 있다(대한민국 등록특허 제10-1315319호, 홍삼추출물과 울금추출물을 포함하는 피로회복용 식품조성물). There is a report that the concentration of creatine phosphokinase in the blood was increased in experimental animals subjected to restraint stress (Korean Patent No. 10-1315319, a food composition for fatigue recovery including red ginseng extract and turmeric extract).
이에 구속 스트레스 유도 후 각 죽염수 또는 식염수가 투여된 동물의 혈액 내 크레아틴포스포키나아제의 양을 표 2에 나타내었다.Accordingly, the amount of creatine phosphokinase in the blood of animals administered with bamboo saline or saline solution after induction of restraint stress is shown in Table 2.
혈중 크레아틴 포스포키나아제(mU/ml)Post restraint stress
Creatine phosphokinase in blood (mU/ml)
표 2에서 보듯이, 혈중 크레아틴 포스포키나아제가 실시예 1 내지 4의 죽염수를 투여한 군에서 현저하게 줄어들었음을 알 수 있다. As shown in Table 2, it can be seen that the blood creatine phosphokinase was significantly reduced in the group to which the bamboo saline solution of Examples 1 to 4 was administered.
<실험예 3. 수영 운동을 통한 항 피로 효과 확인><Experimental Example 3. Confirmation of anti-fatigue effect through swimming exercise>
실험예 3-1. 수영(swimming) 운동 테스트 Experimental Example 3-1. Swimming exercise test
각 죽염수 또는 식염수의 2주간 투여군 그룹에 수영(swimming) 운동부하 실험을 실시하였다. 수영 운동부하 실험은 체중 5% 무게의 추를 목의 배면부위에 매단 후 항온 수조에 입수시키고 탈진 판정(코가 수면 아래로 잠길 정도의 수영이 5 초간 진행되어 가라앉게 된 때) 직후 총 수영시간을 기록하였다. 탈진 직후 곧바로 희생하여 시료(혈청 혹은 혈장)를 채취하였다. A swimming exercise load experiment was conducted in each group of bamboo saline or saline solution administered for 2 weeks. In the swimming exercise load test, a weight of 5% body weight was hung on the back of the neck, received in a constant temperature water tank, and the total swimming time immediately after the determination of exhaustion (when swimming so that the nose was submerged for 5 seconds and then subsided) was measured. Recorded. Immediately after exhaustion, a sample (serum or plasma) was collected by sacrificing.
항 피로효과를 평가하기 위하여 운동지속시간과 혈액 내 글루코오스(glucose), 젖산(lactic acid)의 양을 측정하였다. To evaluate the anti-fatigue effect, the duration of exercise and the amount of glucose and lactic acid in the blood were measured.
실험예 3-2. 수영시간 비교Experimental Example 3-2. Swimming time comparison
각 죽염수 또는 식염수가 투여된 실험동물의 수영시간을 측정하여 하기 표 3에 나타내었다. The swimming time of the experimental animals to which each bamboo saline solution or saline solution was administered was measured and shown in Table 3 below.
표 3에서 보듯이, 실시예 1 내지 5의 죽염수를 투여한 군에서는 타 투여군에 비해 육체적 피로가 해소되어 운동시간이 증가하였음을 확인할 수 있었다.As shown in Table 3, it was confirmed that in the group to which the bamboo saline solution of Examples 1 to 5 was administered, physical fatigue was relieved and exercise time was increased compared to other administration groups.
실험예 3-3. 혈액 내 젖산(lactic acid) 양 비교Experimental Example 3-3. Comparison of the amount of lactic acid in the blood
각 죽염수 또는 식염수가 투여된 실험동물의 수영 후의 혈액 내 젖산농도를 측정한 결과를 표 4에 나타내었다.Table 4 shows the results of measuring the concentration of lactic acid in the blood after swimming of the experimental animals administered with bamboo saline or saline solution.
표 4에서 보듯이, 실시예 1 내지 5의 죽염수를 처리한 군에서는 타 처리군에 비해 육체적 피로가 해소되어 혈액 내 산소공급부족으로 발생하는 젖산 증가량이 효과적으로 억제되었음을 알 수 있었다.As shown in Table 4, in the group treated with the bamboo saline solution of Examples 1 to 5, it was found that the increased amount of lactic acid caused by insufficient oxygen supply in the blood was effectively suppressed by relieving physical fatigue compared to the other treatment groups.
<실험예 4. 트레드밀 운동을 통한 항 피로 효과 확인> <Experimental Example 4. Confirmation of anti-fatigue effect through treadmill exercise>
실험예 4-1. 트레드밀(treadmill) 운동 테스트 Experimental Example 4-1. Treadmill exercise test
일정량의 전기자극을 주어 마우스나 레트가 지속적으로 뛸 수 있도록 제조된 트레드밀을 경사각 5°, 주행속도 5m/min로 세팅하고, 각 실험동물군이 매일 20분씩 7일간 뛰게 한 후 혈액을 채취하여 이전과 같은 방법으로 각 실험을 진행하였다. A treadmill manufactured so that a mouse or rat can run continuously by applying a certain amount of electrical stimulation is set at an inclination angle of 5° and a running speed of 5 m/min, and each experimental animal group is allowed to run for 20 minutes each day for 7 days, and then blood is collected and transferred. Each experiment was carried out in the same way as described above.
실험예 4-2. 혈액 내 젖산(lactic acid) 양 비교Experimental Example 4-2. Comparison of the amount of lactic acid in the blood
트레이드밀 운동을 실시한 실시한 동물군들의 혈액 내 젖산을 비교하여 하기 표 5와 같은 결과를 얻었고, 이 실험에서도 역시 실시예 1 내지 4의 죽염수 투여군에서의 젖산 생성량이 줄어들어 있음을 알 수 있다. By comparing the lactic acid in the blood of the animal groups subjected to the trade mill exercise, the results shown in Table 5 were obtained, and in this experiment, it can also be seen that the amount of lactic acid produced in the bamboo saline administration group of Examples 1 to 4 was reduced.
실험예 4-3. 혈액 내 글루코오스 (glucose)의 양 비교Experimental Example 4-3. Comparison of the amount of glucose in the blood
트레이드밀 운동을 실시한 실시한 동물군들의 혈액 내 글루코오스를 비교하여 하기 표 6과 같은 결과를 얻었고, 이 실험에서도 역시 실시예 1 내지 4의 죽염수 투여군에서의 글루코오스 소모량이 많음을 알 수 있다. By comparing the glucose in the blood of the animal groups subjected to the trade mill exercise, the results shown in Table 6 were obtained, and in this experiment, it can also be seen that the amount of glucose consumed in the bamboo saline administration group of Examples 1 to 4 was large.
<실험예 5. 복용 테스트 - 피로회복 개선효과 확인><Experimental Example 5. Dosing test-Fatigue recovery improvement effect confirmation>
각 7명씩 30대의 성인 남성에게 20일간, 매일 하루에 1시간의 수영 및 1시간의 트레이드밀 운동 동안 실시예 1 내지 4, 비교예 1 내지 10의 죽염수 또는 식염수를 500㎖ 음용하게 하고 20일간의 복용 후 피로감 개선 정도를 하기 표 9에 5점 리커트측정법(5점 : 아주 우수, 4점 : 우수함, 3점 : 보통, 2점 : 나쁨, 1점 : 아주 나쁨)으로 각 조성물의 복용 전과 비교하여 나타내게 하였다. 이를 위해 숙면 효과, 무기력감 개선 효과, 전체적인 피로감 개선 효과 등을 확인하여 표 7에 나타내었다.Each of 7 men in their 30s was allowed to drink 500 ml of bamboo saline or saline solution of Examples 1 to 4 and Comparative Examples 1 to 10 for 20 days, 1 hour of swimming per day and 1 hour of trade mill exercise every day. The degree of improvement in fatigue after taking is compared with before taking each composition in a 5-point Likert measurement method (5 points: very good, 4 points: excellent, 3 points: normal, 2 points: bad, 1 point: very bad). To show. To this end, the effect of improving the sleep effect, the feeling of helplessness, and the effect of improving the overall feeling of fatigue were confirmed and shown in Table 7.
표 7에서 보듯이, 실시예 1 내지 4의 죽염수를 처리한 군에서는 비교예 1 내지 10 복용군에 비해 숙면효과 및 피로감 개선효과가 있었음을 알 수 있다. As shown in Table 7, it can be seen that in the group treated with bamboo saline water of Examples 1 to 4, there was a sound sleep effect and an effect of improving fatigue compared to the group taking Comparative Examples 1 to 10.
따라서, 본 발명의 조성물이 스트레스 완화 효능, 항피로 효능 또는 지구력 증강 효능이 매우 우수함을 알 수 있으며, 이러한 기능을 통해 운동을 통해 체력을 증진하려는 이들이나, 유소년기, 청소년기의 학생, 수험생, 노년층, 회복기의 환자, 재활운동 중의 환자 등의 체력회복용 고급 음료로의 이용이 가능함을 확인할 수 있다. 또한, 이상과 같은 결과를 통해, 본 발명으로 제조된 죽염수가 일반 정제수 추출음료나 용매 추출물을 이용한 음료와 비교하여 생리활성기능이 좋아지는 것은 칼슘이 강화된 죽염을 생리식염수 농도와 비슷한 농도로 사용하면서 기존 사용되던 올리고당이나 설탕 등의 감미료 대신 천연 단백질 감미 성분인 모넬린과 타우마틴을 사용하다는 것에 있는 것으로 파악된다. Therefore, it can be seen that the composition of the present invention has excellent stress relief effect, anti-fatigue effect, or endurance enhancing effect, and those who want to improve physical strength through exercise through these functions, youth, adolescent students, examinees, and the elderly , It can be seen that it can be used as a high-quality drink for physical strength recovery for patients in recovery period and patients during rehabilitation exercise. In addition, through the above results, the physiological activity function of the bamboo saline produced by the present invention is improved compared to that of a general purified water extract or a drink using a solvent extract. It is believed that the use of natural protein sweeteners, monelin and taumatin, is used instead of sweeteners such as oligosaccharides and sugars.
Claims (5)
(제2단계) 상기 죽염을 염도 0.8~1.0 %(w/v)가 되도록 생수에 현탁하여 18~24시간 동안 4~10℃에서 10~30rpm으로 교반한 후 불용성 물질을 제거하여 칼슘(Ca2+) 함량이 증강된 죽염생수를 제조하는 단계;
(제3단계) 상기 제2단계에서 얻은 죽염생수에 애엽, 현호색, 도라지잎, 제주조릿대를 넣고 18~24시간 동안 4~10℃에서 10~30rpm으로 교반한 후 여과하여 생약침출 죽염생수를 제조하는 단계;
(제4단계) 상기 제3단계에서 얻은 생약침출 죽염생수를 62~65℃에서 30~40분간 유지하여 저온살균하는 단계; 및,
(제5단계) 저온살균 후 생약침출 죽염생수에 모넬린 및 타우마틴을 첨가하고 자외선 살균하여 멸균팩에 봉입하는 단계;
를 포함하여 제조되는 것을 특징하는 피로 완화용 죽염수의 제조방법.(First step) preparing bamboo salt containing CaO by mixing the sea salt with bamboo and oyster shells in a weight ratio of 1:0.5:0.5 to 1:2:2 and firing at 900 to 1200°C for 6 to 24 hours;
(Second step) The bamboo salt is suspended in bottled water so that its salinity is 0.8 to 1.0% (w/v), stirred at 4 to 10°C for 18 to 24 hours at 10 to 30 rpm, and then insoluble substances are removed to remove calcium (Ca 2 + ) Preparing bamboo salt mineral water with enhanced content;
(Third step) In the bamboo salted water obtained in the second step, add aeop, hyeonho color, bellflower leaves, and jeju joritdae, stir at 4 to 10°C for 18 to 24 hours at 10 to 30 rpm, and then filter to prepare a herbal medicine leaching bamboo salt water. The step of doing;
(Step 4) Pasteurizing by maintaining the herbal medicine leaching bamboo salt mineral water obtained in the third step at 62 to 65°C for 30 to 40 minutes; And,
(Step 5) adding monelin and taumatin to the herbal medicine leaching bamboo salt water after pasteurization, UV sterilization, and encapsulating in a sterilization pack;
A method for producing bamboo salt water for fatigue relief, characterized in that produced, including.
상기 죽염수는 코티졸, 포스포키나아제 및 젖산 중에서 선택되는 1종 이상 물질의 분비를 억제하는 효능이 있는 것을 특징으로 하는 피로 완화용 죽염수.The method of claim 3,
The bamboo salt water is bamboo salt water for fatigue relief, characterized in that it has the effect of inhibiting the secretion of one or more substances selected from cortisol, phosphokinase and lactic acid.
상기 죽염수는 혈액 내 글루코오스 소모량을 증강시키는 효능이 있는 것을 특징으로 하는 피로 완화용 죽염수.
The method of claim 3,
The bamboo salt water is bamboo salt water for fatigue relief, characterized in that it has the effect of enhancing the consumption of glucose in the blood.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020200044135A KR102234653B1 (en) | 2020-04-10 | 2020-04-10 | Manufacturing method of bamboo salt water with enhanced anti-fatigue after aerobic exercise |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020200044135A KR102234653B1 (en) | 2020-04-10 | 2020-04-10 | Manufacturing method of bamboo salt water with enhanced anti-fatigue after aerobic exercise |
Publications (1)
Publication Number | Publication Date |
---|---|
KR102234653B1 true KR102234653B1 (en) | 2021-03-31 |
Family
ID=75238015
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020200044135A KR102234653B1 (en) | 2020-04-10 | 2020-04-10 | Manufacturing method of bamboo salt water with enhanced anti-fatigue after aerobic exercise |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR102234653B1 (en) |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100893203B1 (en) | 2007-08-23 | 2009-04-16 | 최은아 | Pharmaceurtic Complex Using Distilled Water Comprising Bamboo salt |
KR20100003081A (en) * | 2008-06-30 | 2010-01-07 | 목포대학교산학협력단 | Sports beverage composition |
KR20110035200A (en) * | 2009-09-30 | 2011-04-06 | 송춘종 | Functional food containing honey and bamboo salt and a manufacturing method thereof |
KR101281237B1 (en) | 2010-08-12 | 2013-07-02 | 김광회 | Jukium-Jijangsu and method thereof |
KR20140036966A (en) * | 2012-09-17 | 2014-03-26 | 제주대학교 산학협력단 | Composition for improving exercise capacity or a composition for reducing fatigue using leaves of sasa quelpaertensis |
KR101733700B1 (en) * | 2015-11-25 | 2017-05-08 | 최선희 | Production method of natural fermentation food |
-
2020
- 2020-04-10 KR KR1020200044135A patent/KR102234653B1/en active IP Right Grant
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100893203B1 (en) | 2007-08-23 | 2009-04-16 | 최은아 | Pharmaceurtic Complex Using Distilled Water Comprising Bamboo salt |
KR20100003081A (en) * | 2008-06-30 | 2010-01-07 | 목포대학교산학협력단 | Sports beverage composition |
KR20110035200A (en) * | 2009-09-30 | 2011-04-06 | 송춘종 | Functional food containing honey and bamboo salt and a manufacturing method thereof |
KR101281237B1 (en) | 2010-08-12 | 2013-07-02 | 김광회 | Jukium-Jijangsu and method thereof |
KR20140036966A (en) * | 2012-09-17 | 2014-03-26 | 제주대학교 산학협력단 | Composition for improving exercise capacity or a composition for reducing fatigue using leaves of sasa quelpaertensis |
KR101733700B1 (en) * | 2015-11-25 | 2017-05-08 | 최선희 | Production method of natural fermentation food |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN105451577B (en) | Food, beverage composition and medical component containing fermentation east cactus and the preparation method for east cactus of fermenting | |
CN103005558A (en) | Spleen tonifying and appetite promoting drink and preparation method thereof | |
CN102160664A (en) | Nutritious drink for children | |
CN113907349A (en) | Food for nourishing heart, regulating liver, clearing heart and helping sleep and preparation method thereof | |
CN103340291A (en) | Chinese herbal feed modifier for improving meat quality of livestock and poultry and quality of fresh eggs | |
CN106962904A (en) | Ward off Gu Dan and preparation method thereof | |
CN102613461B (en) | Rapidly beautifying and weight losing nourishment and preparation method thereof | |
KR102234653B1 (en) | Manufacturing method of bamboo salt water with enhanced anti-fatigue after aerobic exercise | |
CN102657304A (en) | Health-care food with double functions of promoting digestion and relieving physical fatigue | |
CN104256607A (en) | Sea cucumber and saussurea involucrate healthcare product | |
Wijayanti et al. | Saponin maintaining and dose determining in carica papaya leaf cookies as a breast milk booster (galactogogue) | |
CN103920140B (en) | A kind of people is with blood sugar lowering Weight-reducing and lipid-lowering compound preparation | |
CN103238895A (en) | Digestion-promotion apple vinegar health beverage and preparation method thereof | |
WO2007090504A1 (en) | Hydrolysed collagen and uses therof | |
CN106255502A (en) | Satiety continues agent and makes the lasting method of satiety | |
CN115944091A (en) | Anti-fatigue tablet and preparation method and application thereof | |
CN109805235B (en) | Wheat-flavor composite polypeptide solid beverage for assisting in reducing hypertension, hyperglycemia and hyperlipidemia, and preparation method and application thereof | |
WO2017186954A1 (en) | Method for the improvement of speed and endurance capacity | |
KR101439792B1 (en) | Oriental medicine composition for children's underweight and respiratory organ, and oriental medicine extracts derived therefrom, and method of preparing the same | |
CN106256220A (en) | A kind of Fructus Mangifera Indicae Herba Passiflorae Caeruleae mulse and preparation method thereof | |
CN106177634A (en) | A kind of weight-reducing compound preparation and preparation method thereof | |
KR101041044B1 (en) | A composition for reducing sleep induction time and prolonging sleeping time, and a method for preparing the same | |
CN105265650A (en) | Health tea and preparation method thereof | |
CN111685330A (en) | Food formula capable of improving immunity | |
CN109200183A (en) | A kind of herbal composite and preparation method thereof and product |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
GRNT | Written decision to grant |